Obstetric medicine · 2026
Use of amlodipine to treat postpartum hypertension.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gerretsen Hannah, Nana Melanie, Nelson-Piercy Catherine
Аннотация
BACKGROUND: Hypertension can arise de novo or persist in the postnatal period. Limited data exist regarding the use of amlodipine in the postpartum period.
MATERIALS AND METHODS: A service evaluation of women prescribed amlodipine postnatally in the maternity department at Guy's and St Thomas' NHS Foundation Trust from April to November 2020 was conducted. Data were obtained by reviewing hospital records and conducting a telephone survey.
RESULTS: Of the 100 women who were prescribed postnatal amlodipine, 43 completed the telephone survey and were included in the analysis. There were no stillbirths, neonatal deaths or significant congenital malformations. Duration of treatment varied from less than 1 week to 1 year postpartum. None of the women taking amlodipine during breastfeeding reported any problems: 23/43 (53.5%) exclusively breastfed and 10/43 (23.3%) mixed-fed.
DISCUSSION: We report the largest case series of postpartum amlodipine use, providing reassuring data regarding its safety and efficacy in this population.
MATERIALS AND METHODS: A service evaluation of women prescribed amlodipine postnatally in the maternity department at Guy's and St Thomas' NHS Foundation Trust from April to November 2020 was conducted. Data were obtained by reviewing hospital records and conducting a telephone survey.
RESULTS: Of the 100 women who were prescribed postnatal amlodipine, 43 completed the telephone survey and were included in the analysis. There were no stillbirths, neonatal deaths or significant congenital malformations. Duration of treatment varied from less than 1 week to 1 year postpartum. None of the women taking amlodipine during breastfeeding reported any problems: 23/43 (53.5%) exclusively breastfed and 10/43 (23.3%) mixed-fed.
DISCUSSION: We report the largest case series of postpartum amlodipine use, providing reassuring data regarding its safety and efficacy in this population.